There’s been upgraded price targets set anywhere between $12 and $20 dollars and also have earnings coming out Aug 2. But if any positive news comes out on the trials could be a whole different story. If Its better than SAGE meds this it could be a launching pad.
Market Data 
Markets 
AI
